Besides, in a controlled experiment in patients with liver fibrosis caused by chronic hepatitis B, fibrosis can be improved more significantly in the group taking YQHX than in the control group, and the activity of YAP in liver and plasma was inhibited through using YQHX.267. The gene discussed is YAP1; the disease is Hepatic fibrosis.